Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Xbrane Biopharma - Filing #689992

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
168 513 SEK
183 226 SEK
Revenue
57 618 SEK
10 709 SEK
Profit (loss) from discontinued operations
4 001 SEK
5 150 SEK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities, discontinued operations
9 876 SEK
10 401 SEK
Cash flows from (used in) operating activities
193 918 SEK
219 610 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities, discontinued operations
SEK
SEK
Cash flows from (used in) investing activities
60 125 SEK
77 350 SEK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities, discontinued operations
SEK
529,000 SEK
Cash flows from (used in) financing activities
148 864 SEK
349 365 SEK
Increase (decrease) in cash and cash equivalents, discontinued operations
53,000 SEK
1 758 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.